The efficacy and safety of low-molecular-weight heparins for venous thromboembolism prophylaxis in abdominal or pelvic cancer surgery: A systematic review and network meta-analysis of randomized controlled trials

被引:0
|
作者
Liu, Kun [1 ]
Hu, Can [1 ]
Zhou, Ling-yun [1 ]
Tang, Zhi-yao [1 ]
Wu, Yi-feng [1 ]
Huang, Yu-jie [1 ]
Zuo, Xiao-cong [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Dept Pharm, Changsha 410013, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, Changsha 410013, Hunan, Peoples R China
关键词
Low-molecular-weight heparins; Cancer; Abdominal or pelvic cancer surgery; Venous thromboembolism; Hemorrhage; Network meta-analysis; PNEUMATIC COMPRESSION; PREVENTION; ENOXAPARIN; SURVIVAL; DEFINITION; GUIDELINES; MANAGEMENT; BREAST;
D O I
10.1016/j.thromres.2025.109294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Low-molecular-weight heparins (LMWHs) have been widely used for thromboprophylaxis in postoperative patients with abdominal or pelvic cancer. However, evidence regarding the optimal type of LMWHs remains limited. Objective: This study aims to evaluate the efficacy and safety of different types of LMWHs in patients undergoing abdominal or pelvic cancer surgery through a network meta-analysis of randomized controlled trials (RCTs). Methods: The network meta-analysis was guided by the PRISMA guidelines. The primary outcomes included venous thromboembolism (VTE), major bleeding, and all-cause death. Results were summarized with relative ratios (RR) and 95 % confidence intervals (CIs). The surface under the cumulative ranking curve (SUCRA) was calculated to assess the performance of various LMWHs. Results: A total of 19 RCTs involving 6318 patients were identified. Compared to non-LMWH, LMWHs significantly reduced the risk of VTE [RR 0.57, (95 % CI 0.41-0.81)], DVT [RR 0.56, (95 % CI 0.39-0.81)], and PE [RR 0.26, (95 % CI 0.10-0.66)], without increasing the risk of all-cause death [RR 0.67, (95 % CI 0.39-1.14)], major bleeding [RR 1.51, (95 % CI 0.82-2.77)], minor bleeding [RR 1.23, (95 % CI 0.84-1.80)], all bleeding [RR 1.35, (95 % CI 0.98-1.84)], or thrombocytopenia [RR 0.41, (95 % CI 0.13-1.31)]. Notably, no significant differences in efficacy and safety were observed among different types of LMWHs, with parnaparin (SUCRA 86.3), dalteparin (SUCRA 74.5), and certoparin (SUCRA 88.5) ranking highest in the prevention of VTE, major bleeding, and allcause death, respectively. Conclusion: LMWHs are efficacious options for thromboprophylaxis in patients undergoing abdominal or pelvic cancer surgery, without increasing the risk of major bleeding or all-cause death. However, no significant differences were observed in efficacy and safety among different types of LMWHs used in this context.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis
    Arce-Huamani, Miguel A.
    Barboza, Joshuan J.
    Martinez-Herrera, Jose Fabian
    Torres-Roman, J. Smith
    Maguina, Jorge L.
    MEDICINA-LITHUANIA, 2023, 59 (10):
  • [32] Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins
    Smrke, Alannah
    Gross, Peter L.
    FRONTIERS IN MEDICINE, 2017, 4
  • [33] Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: Updated systematic review and meta-analysis of randomized controlled trials
    Moik, Florian
    Posch, Florian
    Zielinski, Christoph
    Pabinger, Ingrid
    Ay, Cihan
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 550 - 561
  • [34] Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials
    Thadanipon, Kunlawat
    Anothaisintawee, Thunyarat
    Rattanasiri, Sasivimol
    Thakkinstian, Ammarin
    Attia, John
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (05) : 1435 - 1444
  • [35] Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysis
    Camilli, Massimiliano
    Lombardi, Marco
    Vescovo, Giovanni Maria
    Del Buono, Marco Giuseppe
    Galli, Mattia
    Aspromonte, Nadia
    Zoccai, Giuseppe Biondi
    Niccoli, Giampaolo
    Montone, Rocco A.
    Crea, Filippo
    Minotti, Giorgio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 154
  • [36] Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials
    Ayele, Henok Tadesse
    Brunetti, Vanessa C.
    Renoux, Christel
    Tagalakis, Vicky
    Filion, Kristian B.
    THROMBOSIS RESEARCH, 2021, 199 : 123 - 131
  • [37] The effectiveness of venous thromboembolism prophylaxis interventions in trauma patients: A systematic review and network meta-analysis
    Peng, Serena
    Zhang , Mandy
    Jin, James
    Maccormick, Andrew D.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2023, 54 (12):
  • [38] Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis
    Ying Dong
    Yi Wang
    Rui-Lian Ma
    Ming Liu
    Jun-zhen Gao
    Wu-yun Su
    Li Yan
    Jian-jun Sun
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 400 - 412
  • [39] Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials
    Corinne Frere
    Dominique Farge
    Deborah Schrag
    Pedro H. Prata
    Jean M. Connors
    Journal of Hematology & Oncology, 15
  • [40] Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients A Systematic Review and Meta-analysis
    Tran, Alexandre
    Fernando, Shannon M.
    Carrier, Marc
    Siegal, Deborah M.
    Inaba, Kenji
    Vogt, Kelly
    Engels, Paul T.
    English, Shane W.
    Kanji, Salmaan
    Kyeremanteng, Kwadwo
    Lampron, Jacinthe
    Kim, Dennis
    Rochwerg, Bram
    ANNALS OF SURGERY, 2022, 275 (01) : 19 - 28